Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix and IBM

Premium

Affymetrix and IBM have launched a collaboration designed to help clinicians integrate genomic data with patient data such as medical histories and lab tests, Affymetrix said Tuesday.

The Santa Clara, Calif.-based maker of the GeneChip microarray product line will work with IBM professional services so that data derived from analysis conducted on the company’s proprietary hardware and software platforms can be referenced with medically relevant data as well as used in regulatory compliance efforts.

The announcement brings a prestigious information technology partner, IBM, together with Affymetrix, the leader of the pre-printed microarray market, and focuses on a potentially lucrative area in data management and the challenging process of integrating disparate data seamlessly.

Affymetrix said it plans to work, in collaboration with IBM, to promote open standards and new protocols for cross organizational and cross-disciplinary integration of patient data with genomic and molecular research data.

— MOK

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.